$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.77 | 20,801 | 1,180,810 | 9,842,684 | 9.9 M to 9.8 M (-0.21 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.03 | 27,340 | 1,531,770 | 9,863,485 | 9.9 M to 9.9 M (-0.28 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.43 | 63,985 | 3,802,341 | 9,890,825 | 10 M to 9.9 M (-0.64 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 58.65 | 22,313 | 1,308,631 | 9,954,810 | 10 M to 10 M (-0.22 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 58.62 | 18,241 | 1,069,335 | 9,977,123 | 10 M to 10 M (-0.18 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 58.16 | 68,732 | 3,997,659 | 9,995,364 | 10.1 M to 10 M (-0.68 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.91 | 13,027 | 741,324 | 10,064,096 | 10.1 M to 10.1 M (-0.13 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 60.68 | 9,579 | 581,287 | 10,077,123 | 10.1 M to 10.1 M (-0.09 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.87 | 14,261 | 853,827 | 10,086,702 | 10.1 M to 10.1 M (-0.14 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 58.77 | 23,366 | 1,373,290 | 10,100,963 | 10.1 M to 10.1 M (-0.23 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 57.80 | 11,502 | 664,809 | 10,124,329 | 10.1 M to 10.1 M (-0.11 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.71 | 41,292 | 2,341,814 | 10,135,831 | 10.2 M to 10.1 M (-0.41 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 60.62 | 905 | 54,863 | 10,177,123 | 10.2 M to 10.2 M (-0.01 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 60.02 | 35,716 | 2,143,556 | 10,178,028 | 10.2 M to 10.2 M (-0.35 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.50 | 9,223 | 548,753 | 10,213,744 | 10.2 M to 10.2 M (-0.09 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 62.01 | 200 | 12,402 | 10,222,967 | 10.2 M to 10.2 M (0.00 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 61.12 | 8,925 | 545,473 | 10,223,167 | 10.2 M to 10.2 M (-0.09 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 60.52 | 36,920 | 2,234,291 | 10,232,092 | 10.3 M to 10.2 M (-0.36 %) |
Jul 13 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.28 | 53,955 | 3,198,355 | 10,269,012 | 10.3 M to 10.3 M (-0.52 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 61.56 | 8,554 | 526,564 | 10,322,967 | 10.3 M to 10.3 M (-0.08 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 60.83 | 13,401 | 815,167 | 10,331,521 | 10.3 M to 10.3 M (-0.13 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.83 | 60,018 | 3,590,799 | 10,344,922 | 10.4 M to 10.3 M (-0.58 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 58.92 | 18,027 | 1,062,216 | 10,404,940 | 10.4 M to 10.4 M (-0.17 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.90 | 20,147 | 1,206,705 | 10,422,967 | 10.4 M to 10.4 M (-0.19 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.04 | 56,790 | 3,352,728 | 10,443,114 | 10.5 M to 10.4 M (-0.54 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 57.72 | 2,450 | 141,405 | 10,499,904 | 10.5 M to 10.5 M (-0.02 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 59.57 | 20,379 | 1,214,024 | 10,502,354 | 10.5 M to 10.5 M (-0.19 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 58.85 | 18,486 | 1,087,979 | 10,522,733 | 10.5 M to 10.5 M (-0.18 %) |
Jul 08 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 57.80 | 47,825 | 2,764,118 | 10,541,219 | 10.6 M to 10.5 M (-0.45 %) |
Jul 07 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 57.98 | 35,988 | 2,086,426 | 10,589,044 | 10.6 M to 10.6 M (-0.34 %) |
Jul 07 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 57.38 | 36,417 | 2,089,666 | 10,625,032 | 10.7 M to 10.6 M (-0.34 %) |
Jul 07 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.47 | 15,376 | 868,343 | 10,661,449 | 10.7 M to 10.7 M (-0.14 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 2,000 | 28,620 | 35,760 | |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 88,753 | 1,270,055 | 37,760 | |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.04 | 2,000 | 130,090 | 2,268,557 | 2.3 M to 2.3 M (-0.09 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 2,000 | 28,620 | 2,270,557 | 2.3 M to 2.3 M (+0.09 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.08 | 88,753 | 5,775,877 | 2,268,557 | 2.4 M to 2.3 M (-3.77 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 88,753 | 1,270,055 | 2,357,310 | 2.3 M to 2.4 M (+3.91 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 11.02 | 20,000 | 220,400 | 60,000 | |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 30,000 | 245,700 | 67,132 | |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 64.58 | 50,000 | 3,229,035 | 91,317 | 141.3 K to 91.3 K (-35.38 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 11.02 | 20,000 | 220,400 | 141,317 | 121.3 K to 141.3 K (+16.49 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 30,000 | 245,700 | 121,317 | 91.3 K to 121.3 K (+32.85 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 10.86 | 33,541 | 364,255 | 36,459 | |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 65.10 | 33,541 | 2,183,519 | 76,247 | 109.8 K to 76.2 K (-30.55 %) |
Jun 16 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 10.86 | 33,541 | 364,255 | 109,788 | 76.2 K to 109.8 K (+43.99 %) |
Jun 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 6.62 | 1,583 | 10,479 | 108,417 | |
Jun 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 6.23 | 5,208 | 32,446 | 44,792 | |
Jun 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 3,959 | 14,134 | 87,826 | |
Jun 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 6.62 | 1,583 | 10,479 | 104,930 | 103.3 K to 104.9 K (+1.53 %) |
Jun 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 6.23 | 5,208 | 32,446 | 103,347 | 98.1 K to 103.3 K (+5.31 %) |
Jun 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 3,959 | 14,134 | 98,139 | 94.2 K to 98.1 K (+4.20 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.62 | 19,612 | 129,831 | 24,375 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.62 | 40,867 | 270,540 | 43,987 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.62 | 2,800 | 18,536 | 84,854 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 60.34 | 19,612 | 1,183,423 | 76,247 | 95.9 K to 76.2 K (-20.46 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.62 | 19,612 | 129,831 | 95,859 | 76.2 K to 95.9 K (+25.72 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 60.06 | 40,867 | 2,454,525 | 76,247 | 117.1 K to 76.2 K (-34.90 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.62 | 40,867 | 270,540 | 117,114 | 76.2 K to 117.1 K (+53.60 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 60.00 | 2,800 | 167,986 | 76,247 | 79 K to 76.2 K (-3.54 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.62 | 2,800 | 18,536 | 79,047 | 76.2 K to 79 K (+3.67 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 7,724 | 0 | 0 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 7,724 | 0 | 13,069 | 5.3 K to 13.1 K (+144.51 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 7,724 | 0 | 0 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 7,724 | 0 | 111,913 | 104.2 K to 111.9 K (+7.41 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 4,660 | 0 | 65,023 | 60.4 K to 65 K (+7.72 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Grant | A | 0.00 | 4,660 | 0 | 102,901 | 98.2 K to 102.9 K (+4.74 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Grant | A | 0.00 | 4,660 | 0 | 166,357 | 161.7 K to 166.4 K (+2.88 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 35,865 | 513,228 | 126,513 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 70,608 | 1,010,400 | 162,378 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 4,201 | 60,116 | 232,986 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 57.75 | 35,865 | 2,071,100 | 2,268,557 | 2.3 M to 2.3 M (-1.56 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 35,865 | 513,228 | 2,304,422 | 2.3 M to 2.3 M (+1.58 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 56.14 | 16,029 | 899,874 | 2,268,557 | 2.3 M to 2.3 M (-0.70 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 55.33 | 54,579 | 3,019,856 | 2,284,586 | 2.3 M to 2.3 M (-2.33 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 70,608 | 1,010,400 | 2,339,165 | 2.3 M to 2.3 M (+3.11 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 55.01 | 4,201 | 231,115 | 2,268,557 | 2.3 M to 2.3 M (-0.18 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 4,201 | 60,116 | 2,272,758 | 2.3 M to 2.3 M (+0.19 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 3.57 | 34,222 | 122,173 | 5,606 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 3.57 | 4,312 | 15,394 | 39,828 | |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 55.11 | 34,222 | 1,886,135 | 76,247 | 110.5 K to 76.2 K (-30.98 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 3.57 | 34,222 | 122,173 | 110,469 | 76.2 K to 110.5 K (+44.88 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 50.01 | 4,312 | 215,639 | 76,247 | 80.6 K to 76.2 K (-5.35 %) |
May 12 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 3.57 | 4,312 | 15,394 | 80,559 | 76.2 K to 80.6 K (+5.66 %) |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 8,851 | 126,658 | 237,187 | |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 55.01 | 8,851 | 486,851 | 2,268,557 | 2.3 M to 2.3 M (-0.39 %) |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 8,851 | 126,658 | 2,277,408 | 2.3 M to 2.3 M (+0.39 %) |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 3.57 | 8,860 | 31,630 | 44,140 | |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 55.01 | 8,860 | 487,345 | 76,247 | 85.1 K to 76.2 K (-10.41 %) |
May 07 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 3.57 | 8,860 | 31,630 | 85,107 | 76.2 K to 85.1 K (+11.62 %) |
May 06 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 20,123 | 164,807 | 97,132 | |
May 06 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 54,877 | 449,443 | 117,255 | |
May 06 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 54.73 | 20,123 | 1,101,237 | 91,317 | 111.4 K to 91.3 K (-18.06 %) |
May 06 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 20,123 | 164,807 | 111,440 | 91.3 K to 111.4 K (+22.04 %) |
May 06 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 54.57 | 54,877 | 2,994,819 | 91,317 | 146.2 K to 91.3 K (-37.54 %) |
May 06 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 54,877 | 449,443 | 146,194 | 91.3 K to 146.2 K (+60.10 %) |
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | A | 46.52 | 16,510 | 768,045 | 16,510 | |
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | M | 0.00 | 5,251 | 0 | 10,502 | |
Mar 31 2020 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Buy | M | 0.00 | 5,251 | 0 | 12,975 | 7.7 K to 13 K (+67.98 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 38.21 | 860 | 32,863 | 49,600 | 50.5 K to 49.6 K (-1.70 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 37.40 | 13,959 | 522,008 | 50,460 | 64.4 K to 50.5 K (-21.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 36.72 | 9,181 | 337,100 | 64,419 | 73.6 K to 64.4 K (-12.47 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 35.32 | 2,801 | 98,932 | 73,600 | 76.4 K to 73.6 K (-3.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 34.43 | 3,199 | 110,147 | 76,401 | 79.6 K to 76.4 K (-4.02 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 46.59 | 71,500 | 3,331,185 | 71,500 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 103,700 | 0 | 103,700 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 40,844 | 584,478 | 246,038 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.35 | 40,844 | 2,056,691 | 2,268,557 | 2.3 M to 2.3 M (-1.77 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 40,844 | 584,478 | 2,309,401 | 2.3 M to 2.3 M (+1.80 %) |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 46.59 | 21,400 | 997,026 | 21,400 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 0.00 | 31,000 | 0 | 31,000 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 46.59 | 16,100 | 750,099 | 16,100 | |
Mar 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 0.00 | 23,300 | 0 | 23,300 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 15,341 | 219,530 | 286,882 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 63,340 | 906,395 | 302,223 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 51.10 | 29 | 1,482 | 2,268,557 | 2.3 M to 2.3 M (0.00 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.21 | 15,312 | 768,814 | 2,268,586 | 2.3 M to 2.3 M (-0.67 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 15,341 | 219,530 | 2,283,898 | 2.3 M to 2.3 M (+0.68 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 51.14 | 7,723 | 394,977 | 2,268,557 | 2.3 M to 2.3 M (-0.34 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 50.41 | 55,617 | 2,803,536 | 2,276,280 | 2.3 M to 2.3 M (-2.39 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 63,340 | 906,395 | 2,331,897 | 2.3 M to 2.3 M (+2.79 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 24,200 | 262,812 | 55,000 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 50.63 | 3,200 | 162,013 | 94,180 | 97.4 K to 94.2 K (-3.29 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 50.06 | 21,000 | 1,051,208 | 97,380 | 118.4 K to 97.4 K (-17.74 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 24,200 | 262,812 | 118,380 | 94.2 K to 118.4 K (+25.70 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 42,631 | 349,148 | 0 | |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 50.99 | 1,163 | 59,306 | 76,247 | 77.4 K to 76.2 K (-1.50 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 50.34 | 41,468 | 2,087,391 | 77,410 | 118.9 K to 77.4 K (-34.88 %) |
Feb 21 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 42,631 | 349,148 | 118,878 | 76.2 K to 118.9 K (+55.91 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 26,600 | 288,876 | 79,200 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 1,400 | 15,204 | 105,800 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.86 | 2,800 | 30,408 | 107,200 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 18,700 | 153,153 | 172,132 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 1,100 | 9,009 | 190,832 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 200 | 1,638 | 191,932 | |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 49.61 | 45,300 | 2,247,147 | 94,180 | 139.5 K to 94.2 K (-32.48 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 26,600 | 288,876 | 139,480 | 112.9 K to 139.5 K (+23.56 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 18,700 | 153,153 | 112,880 | 94.2 K to 112.9 K (+19.86 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 49.51 | 2,500 | 123,776 | 94,180 | 96.7 K to 94.2 K (-2.59 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 1,400 | 15,204 | 96,680 | 95.3 K to 96.7 K (+1.47 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 1,100 | 9,009 | 95,280 | 94.2 K to 95.3 K (+1.17 %) |